| 000 | 01582 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513002923.0 | ||
| 264 | 0 | _c19800514 | |
| 008 | 198005s 0 0 eng d | ||
| 022 | _a0004-3591 | ||
| 024 | 7 |
_a10.1002/art.1780230207 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiller, B | |
| 245 | 0 | 0 |
_aDouble-blind placebo controlled crossover evaluation of levamisole in rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bArthritis and rheumatism _cFeb 1980 |
||
| 300 |
_a172-82 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAgranulocytosis _xchemically induced |
| 650 | 0 | 4 | _aAntibody Formation |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdiagnostic imaging |
| 650 | 0 | 4 | _aBlood Sedimentation |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aComplement System Proteins |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Cellular |
| 650 | 0 | 4 | _aImmunoglobulins |
| 650 | 0 | 4 |
_aLevamisole _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aRadiography |
| 700 | 1 | _ade Merieux, P | |
| 700 | 1 | _aSrinivasan, R | |
| 700 | 1 | _aClements, P | |
| 700 | 1 | _aFan, P | |
| 700 | 1 | _aLevy, J | |
| 700 | 1 | _aPaulus, H E | |
| 773 | 0 |
_tArthritis and rheumatism _gvol. 23 _gno. 2 _gp. 172-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.1780230207 _zAvailable from publisher's website |
| 999 |
_c6987655 _d6987655 |
||